Agfa-Gevaert Q2 2025 Results: Strong HealthCare IT Performance, Stable Digital Print & Chemicals, Decline in Medical Film Markets

miércoles, 27 de agosto de 2025, 1:46 am ET1 min de lectura

Agfa-Gevaert Group Q2 2025 results show strong HealthCare IT performance and stable Digital Print & Chemicals performance, but a further decline in medical film. Adjusted EBITDA decreased to 13 million euro, while net profit reached 30 million euro due to a positive impact from the final award in the AgfaPhoto arbitration. A new 3-year revolving credit facility of 180 million euro was signed.

Agfa-Gevaert Q2 2025 Results: Strong HealthCare IT Performance, Stable Digital Print & Chemicals, Decline in Medical Film Markets

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios